Vitamin D and C-reactive protein: A mendelian randomization study

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Liefaard, Marte C ^a,b   Ligthart, Symen ^a   Vitezova, Anna ^a   Hofman, Albert ^a   Uitterlinden, André G ^a   Jong, Jessica C Kiefte De ^a   Franco, Oscar H ^a   Zillikens, M Carola ^a   Dehghan, Abbas ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Netherlands Institute for Health Sciences ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; VITAMIN D;

AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNE SYSTEM; INFLAMMATION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; NON COMMUNICABLE DISEASE; OBSERVATIONAL STUDY; PREVALENCE; PROSPECTIVE STUDY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; FEMALE; GENETICS; METABOLISM; MIDDLE AGED; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; GENOTYPE; HUMANS; LINEAR MODELS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84940063606     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131740     Document Type: Article

References (36)

1. Holick MF. Vitamin D deficiency. The New England journal of medicine. 2007;357(3):266-81. PMID: 17634462
2. Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM. Specific high-affinity receptors for 1, 25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab. 1983;57(6):1308-10. PMID: 6313738
3. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1, 25-dihydroxyvitamin D3 receptors in human leukocytes. Science. 1983;221(4616):1181-3. PMID: 6310748
4. Guillot X, Semerano L, Saidenberg-Kermanac'h N, Falgarone G, Boissier MC. Vitamin D and inflammation. Joint Bone Spine. 2010;77(6):552-7. doi: 10.1016/j.jbspin. 2010.09.018 PMID: 21067953
5. Donath MY, Ehses JA, Maedler K, Schumann DM, Ellingsgaard H, Eppler E, et al. Mechanisms of beta-cell death in type 2 diabetes. Diabetes. 2005;54 Suppl 2:S108-13. PMID: 16306327
6. Shea MK, Booth SL, Massaro JM, Jacques PF, DAgostino RB Sr., Dawson-Hughes B, et al. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. American journal of epidemiology. 2008;167(3):313-20. PMID: 18006902
7. Michos ED, Streeten EA, Ryan KA, Rampersaud E, Peyser PA, Bielak LF, et al. Serum 25-hydroxyvitamin d levels are not associated with subclinical vascular disease or C-reactive protein in the old order amish. Calcif Tissue Int. 2009;84(3):195-202. doi: 10.1007/s00223-008-9209-3 PMID: 19148561
8. Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum. 2007;56(7):2143-9. PMID: 17599737
9. Amer M, Qayyum R. Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). The American journal of cardiology. 2012;109(2):226-30. doi: 10.1016/j.amjcard.2011.08.032 PMID: 21996139
10. Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, Islam K, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proceedings of the National Academy of Sciences of the United States of America. 2012;109(38):15449-54. PMID: 22949664
11. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe-Court D, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM: monthly journal of the Association of Physicians. 2002;95(12):787-96. PMID: 12454321
12. Chen N, Wan Z, Han SF, Li BY, Zhang ZL, Qin LQ. Effect of vitamin D supplementation on the level of circulating high-sensitivity C-reactive protein: a meta-analysis of randomized controlled trials. Nutrients. 2014;6(6):2206-16. doi: 10.3390/nu6062206 PMID: 24918698
13. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006;83(4):754-9. PMID: 16600924
14. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007;30(4):980-6. PMID: 17277040
15. Bjorkman MP, Sorva AJ, Tilvis RS. C-reactive protein and fibrinogen of bedridden older patients in a six-month vitamin D supplementation trial. J Nutr Health Aging. 2009;13(5):435-9. PMID: 19390750
16. Smith GD, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? International journal of epidemiology. 2003;32(1):1-22. PMID: 12689998
17. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Statistics in medicine. 2008;27(8):1133-63. PMID: 17886233
18. Hofman A, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, Ikram MA, et al. The Rotterdam Study: 2014 objectives and design update. European journal of epidemiology. 2013;28(11):889-926. doi: 10.1007/s10654-013-9866-z PMID: 24258680
19. Hofman A, van Duijn CM, Franco OH, Ikram MA, Janssen HL, Klaver CC, et al. The Rotterdam Study: 2012 objectives and design update. European journal of epidemiology. 2011;26(8):657-86. doi: 10. 1007/s10654-011-9610-5 PMID: 21877163
20. Genomes Project C, Abecasis GR, Auton A, Brooks LD, De Pristo MA, Durbin RM, et al. An integrated map of genetic variation from 1, 092 human genomes. Nature. 2012;491(7422):56-65. doi: 10.1038/nature11632 PMID: 23128226
21. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genetic epidemiology. 2010;34(8):816-34. doi: 10.1002/gepi. 20533 PMID: 21058334
22. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376(9736):180-8. doi: 10.1016/S0140-6736 (10) 60588-0 PMID: 20541252
23. Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C, et al. Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation. 2011;123(7):731-8. doi: 10.1161/CIRCULATIONAHA.110.948570 PMID: 21300955
24. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247-54. PMID: 16908915
25. United Nations Educational SaCOU. International Standard Classification of Education (ISCED) 1976. Available from: http://unesdoc.unesco.org/images/0002/000209/020992eb.pdf.
26. Burger H, van Daele PL, Algra D, van den Ouweland FA, Grobbee DE, Hofman A, et al. The association between age and bone mineral density in men and women aged 55 years and over: the Rotterdam Study. Bone Miner. 1994;25(1):1-13. PMID: 8061547
27. Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int. 1998;8(5):468-89. PMID: 9850356
28. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30. doi: 10.1210/jc.2011-0385 PMID: 21646368
29. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. Bmj. 1995;310(6973):170. PMID: 7833759
30. Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA, et al. Novel loci foradiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45, 891 individuals. PLoS genetics. 2012;8(3):e1002607. doi: 10.1371/journal.pgen. 1002607 PMID: 22479202
31. Holick MF. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Current Opinion in Endocrinology, Diabetes and Obesity. 2002;9(1):87-98.
32. Hewison M, Zehnder D, Chakraverty R, Adams JS. Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. Mol Cell Endocrinol. 2004;215(1-2):31-8. PMID: 15026172
33. Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1, 25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004;80(6 Suppl):1717S-20S. PMID: 15585793
34. Mahon BD, Wittke A, Weaver V, Cantorna MT. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem. 2003;89(5):922-32. PMID: 12874827
35. Zhang Y, Leung DY, Richers BN, Liu Y, Remigio LK, Riches DW, et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012;188(5):2127-35. doi: 10.4049/jimmunol.1102412 PMID: 22301548
36. Dickie LJ, Church LD, Coulthard LR, Mathews RJ, Emery P, McDermott MF. Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes. Rheumatology (Oxford). 2010;49(8):1466-71.